William D. Tap, MD - Achieving Disease Control in TGCT: Critical Steps For Integrating Evidence-Based Care With CSF1R Inhibitors

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PSM865. CME/MOC/AAPA/IPCE credit will be available until December 18, 2026.

Achieving Disease Control in TGCT: Critical Steps For Integrating Evidence-Based Care With CSF1R Inhibitors

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and TGCT Support, a program of The Life Raft Group. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by independent educational grants from Daiichi Sankyo, Inc., Deciphera Pharmaceuticals, and Merck KGaA, Darmstadt, Germany.

Disclosure information is available at the beginning of the video presentation.